Hims & Hers Health, Inc.
HIMSHealthcareNASDAQDrug Manufacturers - Specialty & Generic
Scan Results
Daily timeframeHims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of. With a market capitalization of $6.47B, it sits in mid-cap territory. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
Market Cap
$6.47B
Beta
2.43
P/E (TTM)
—
P/E (Fwd)
37.59
EPS (TTM)
$-0.64
EPS (Fwd)
$0.74
ROE
-32.0%
ROA
-2.2%
Cash
$841.0M
Total Debt
$1.55B
Free CF
$849.4M
52W Change
-43.2%
Annual Financials
Cash vs Debt
Where HIMS stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, HIMS finished 0.57% below its 150-day moving average ($28.31) and 3.30% above its 200-day moving average ($27.25). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HIMS overbought or oversold?
At the October 20, 2026 close, HIMS's RSI(14) was 48.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, HIMS has $841.0M in cash with $1.55B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $849.4M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -32.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $526.9M (2022) to $2.35B (2025), reflecting a 346% increase over the period.
With a beta above 1.5, HIMS tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Hims & Hers Health, Inc. and its sector.